Transmedics Group Inc
NASDAQ:TMDX

Watchlist Manager
Transmedics Group Inc Logo
Transmedics Group Inc
NASDAQ:TMDX
Watchlist
Price: 122.44 USD -1.88%
Market Cap: 4.1B USD

Intrinsic Value

The intrinsic value of one TMDX stock under the Base Case scenario is 43.62 USD. Compared to the current market price of 122.44 USD, Transmedics Group Inc is Overvalued by 64%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

TMDX Intrinsic Value
43.62 USD
Overvaluation 64%
Intrinsic Value
Price
Worst Case
Base Case
Best Case
Compare TMDX to

Fundamental Analysis

Company Overview
Loading...
Business Segments
Loading...
Earnings Call
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about TMDX?
Bearish
Neutral
Bullish
AI Assistant
AI Assistant
Ask me anything about Transmedics Group Inc
Financials
Annual
Quarterly
TTM

Balance Sheet Decomposition
Transmedics Group Inc

Current Assets 505.9m
Cash & Short-Term Investments 310.1m
Receivables 142m
Other Current Assets 53.7m
Non-Current Assets 331.6m
PP&E 317.3m
Intangibles 13.7m
Other Non-Current Assets 711k
Efficiency

Free Cash Flow Analysis
Transmedics Group Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Transmedics Group Inc

Revenue
488.2m USD
Cost of Revenue
-197.9m USD
Gross Profit
290.3m USD
Operating Expenses
-237.8m USD
Operating Income
52.5m USD
Other Expenses
-3.6m USD
Net Income
48.9m USD
Fundamental Scores

TMDX Profitability Score
Profitability Due Diligence

Transmedics Group Inc's profitability score is 44/100. The higher the profitability score, the more profitable the company is.

44/100
Profitability
Score

Transmedics Group Inc's profitability score is 44/100. The higher the profitability score, the more profitable the company is.

TMDX Solvency Score
Solvency Due Diligence

Transmedics Group Inc's solvency score is 48/100. The higher the solvency score, the more solvent the company is.

Short-Term Solvency
Long-Term Solvency
Average Altman Z-Score
Positive Net Debt
48/100
Solvency
Score

Transmedics Group Inc's solvency score is 48/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

TMDX Price Targets Summary
Transmedics Group Inc

Wall Street analysts forecast TMDX stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for TMDX is 141.78 USD with a low forecast of 104.03 USD and a high forecast of 187.95 USD.

Lowest
Price Target
104.03 USD
15% Downside
Average
Price Target
141.78 USD
16% Upside
Highest
Price Target
187.95 USD
54% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Transmedics Group Inc
does not pay dividends
Shareholder Yield

Current shareholder yield for TMDX is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y

Ownership

TMDX Insider Trading
Buy and sell transactions by insiders

What is the Intrinsic Value of one TMDX stock?

The intrinsic value of one TMDX stock under the Base Case scenario is 43.62 USD.

Is TMDX stock undervalued or overvalued?

Compared to the current market price of 122.44 USD, Transmedics Group Inc is Overvalued by 64%.

Back to Top